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Abstract
Background: Only prototypes 5 years ago, high-speed, automated whole slide imaging (WSI) systems
(also called digital slide systems, virtual microscopes or wide field imagers) are becoming increasingly
capable and robust. Modern devices can capture a slide in 5 minutes at spatial sampling periods of less than
0.5 micron/pixel. The capacity to rapidly digitize large numbers of slides should eventually have a profound,
positive impact on pathology. It is important, however, that pathologists validate these systems during
development, not only to identify their limitations but to guide their evolution.
Methods: Three pathologists fully signed out 25 cases representing 31 parts. The laboratory information
system was used to simulate real-world sign-out conditions including entering a full diagnostic field and
comment (when appropriate) and ordering special stains and recuts. For each case, discrepancies between
diagnoses were documented by committee and a "consensus" report was formed and then compared with
the microscope-based, sign-out report from the clinical archive.
Results: In 17 of 25 cases there were no discrepancies between the individual study pathologist reports.
In 8 of the remaining cases, there were 12 discrepancies, including 3 in which image quality could be at
least partially implicated. When the WSI consensus diagnoses were compared with the original sign-out
diagnoses, no significant discrepancies were found. Full text of the pathologist reports, the WSI consensus
diagnoses, and the original sign-out diagnoses are available as an attachment to this publication.
Conclusion: The results indicated that the image information contained in current whole slide images is
sufficient for pathologists to make reliable diagnostic decisions and compose complex diagnostic reports.
This is a very positive result; however, this does not mean that WSI is as good as a microscope. Virtually
every slide had focal areas in which image quality (focus and dynamic range) was less than perfect. In some
cases, there was evidence of over-compression and regions made "soft" by less than perfect focus. We
expect systems will continue to get better, image quality and speed will continue to improve, but that
further validation studies will be needed to guide development of this promising technology.
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Automated, high-speed, high-resolution whole side imag-
ing (WSI) robots, introduced as prototypes only a few
years ago, are becoming increasingly robust and capable.
Current devices can automatically image several hundred
slides per day and these volumes will only increase in the
future. With time, this technology should have a signifi-
cant and beneficial impact on pathology practice as it will
enable pathologists to better apply computational power
and network connectivity to all aspects of their practice,
not just reporting and accessioning. Though several years
off, integrated digitization (gross, slides and text) could
streamline workflows, increase productivity, and allow
new and unforeseen capabilities such as computer-aided
diagnosis (CAD). Despite these promises, however, there
exists only a relatively small number of papers describing
automated WSI in education and research [1-6], far fewer
directly comparing automated WSI with traditional
microscope examination in diagnosis [7-11], and virtually
none describing automated WSI in clinical practice. A
good review of WSI technology and applications can be
found in Gu and Ogilvie [12].
Clinical (diagnostic) validation of WSI systems is
extremely important because image capture is automated,
focusing mechanisms are novel, and the size of the data-
sets they generate mandates the use of lossy compression.
Validation studies are also an important way for patholo-
gists to guide the development of the technology. There is
little question that digitization itself is not a barrier to
pathology diagnosis; for many years pathology practices
have provided remote diagnostic services using robotic
real-time, near real-time and even static image-based
telepathology. For example, Dr. Bruce Dunn and his col-
leagues at the Milwaukee Veterans Administration
reported thousands of successful diagnostic robotic
telepathology sessions with a remote hospital in Iron
Mountain, MI [13]; Dr. Keith Kaplan established an active
robotic telepathology service that now supports 22 army
facilities [14]; and Drs. Marida Minervini and Jake
Demetrius and their colleagues in Pittsburgh used a static
telepathology system to support transplant pathology at a
hospital in Palermo Italy [15]. In these traditional telepa-
thology applications, however, pathologists directly con-
trol the image formation (focus) and capture process. This
is not the case with high-speed WSI systems in which
image formation and capture are automated.
Given the large number of slides generated by pathology
laboratories, one of the most essential features of a clinical
WSI system is slide capture speed (or throughput). Fortu-
nately, modern WSI devices are becoming very fast, with
current devices ranging from 2 to 8 minutes per slide. To
achieve this speed, systems employ a unique focusing
strategy. While some WSI systems can be set to auto-focus
at every point on the slide [16-18], this is a time consum-
ing process. Systems designed for faster speeds tend to pre-
focus on a limited number of points and use proprietary
algorithms to calculate an "in focus surface" above the
slide such that, if the objective lens follows that surface
during capture, the resulting image should be in focus.
While engineers are developing increasingly sophisticated
and successful algorithms, and increasingly capable stages
for implementing these algorithms, perfect focus is rarely
achieved over an entire slide. This is largely because tissue
sections are not planar, especially compared to the depth
of field produced by high numerical aperture 20 × or 40 ×
objectives. Some researchers have suggested that vendors
decrease the numerical aperture of their lenses or stop
down the condenser – effectively trading lower maximal
optical resolution for a deeper depth of field [19]. How-
ever, achieving perfect focus across an entire slide remains
a major challenge for modern high-speed WSI systems
and a potential limitation to their clinical use. Therefore,
the high degree of diagnostic capability expected from a
traditional, microscope-based pathology examination
and reported for robotic telepathology systems (vide
infra) [13-15] cannot be assumed in automated WSI and
must be validated in controlled studies.
In a WSI system, the optics form an image, the focusing
system places the image precisely on the sensor (usually a
CCD) and the CCD/camera samples that image. Captured
images are generally subjected to compression and are
viewed on a wide range of monitors. While the quality of
focus is often considered the most critical aspect of image
quality, these other components (and their interactions)
are also important. In actual practice, if WSI systems have
quality optics with sufficient numerical aperture (as found
in most current devices), and if precise focus is achieved
(vide supra), then the quality of the captured image will
be determined by the quality of the image sampling. Sam-
pling is limited by the spatial sampling period ("pixel res-
olution") [20] and dynamic range of the sensor. Spatial
sampling period is calculated by dividing the size of a
pixel by the primary optical magnification of the system.
For example, a CCD with 6.6 micron pixels and 20 ×
objective lens gives a sampling period of 333 nanometers.
While manufacturers (and users) often tout spatial sam-
pling period as a proxy for image quality, in reality cap-
tured image quality is a function of many parameters
(including optical resolution, focus, spatial sampling
period and dynamic range) and relationships between
these variables are complex issues well beyond the scope
of this paper [21]. To improve image quality, for example,
one may choose to decrease (improve) the spatial sam-
pling period by increasing the magnification or decreasing
the pixel size. However, these changes can have unin-
tended consequences: increasing magnification often
increases numeric aperture which could affect focus whilePage 2 of 19
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decrease image quality. The point is that relationships
between image quality, optical resolution, sampling
period, dynamic range, etc. are complex and ideal combi-
nations cannot be easily predicted. Again, careful study,
testing and validation are needed to guide development
and practice.
Another important parameter that impacts image quality
is the use of compression. The effect of compression on
traditional static and dynamic telepathology has been
well studied [22]. A typical WSI system with a sampling
period of 0.33 um/pixel generates 900 million image pix-
els per square centimeter of tissue section. At 24 bit color,
this is 2.7 GB of data per square centimeter. Therefore, all
high-speed WSI devices use lossy compression as a matter
of course. Although it is our experience that "reasonable"
compression, especially using JPG or JG2000 algorithms,
provides excellent image quality with limited artifact, the
effect of compression has not been carefully studied on
WSI diagnosis and its clinical impact (or lack there of)
should not be taken on faith.
These considerations and many others make it clear that,
for automated, high-speed WSI to reach its potential in
pathology practice, it must be continuously evaluated and
validated by the pathology community. In this paper we
present a retrospective validation study based on 25 ran-
domly selected genitourinary and dermatopathology
cases. Our goal was to determine if pathologists could
effectively sign-out complex cases (full final diagnosis
field with comment) exclusively through whole slide
images captured by a modern imaging robot. We also
wanted to establish a level of baseline diagnostic capabil-
ity for pathologists evaluating WSI for their practices and
to identify problem areas that could be addressed by
future focused studies.
Methods
Study design and participants
This was a retrospective, comparative study evaluating the
use of automated, high-speed WSI in a routine clinical
activity: primary diagnosis sign-out. The study took place
in the Division of Anatomic Pathology at University of
Pittsburgh Medical Center, Shadyside Hospital, a 486-bed
academic tertiary care hospital. The division had nine fac-
ulty (sign-out) pathologists. They were all teaching faculty
of the University of Pittsburgh with between 2 – 30 years
of practice experience (mean = 12.8), board certifications,
and fellowship training in at least one area. Three had spe-
cific formal training in GU pathology, three others con-
sider GU pathology an area of interest or strength, and
two had specific training in dermatopathology. Faculty
offices and sign-out rooms were equipped with Olympus
BX45 microscopes. The objective lenses were Plan Apo
(magnifications range from 2 – 100 ×) and the scopes
were professionally calibrated twice a year. Cases were
signed out with the assistance of residents and fellows.
Three anatomic pathologists from the division with a spe-
cial interest in this research volunteered participation as
subjects in this study. The pathologists had at least two
years of experience using WSI for education and case pres-
entation and had participated in at least one prior WSI
validation study. They included a board certified patholo-
gist/dermatopathologist with an interest in genitourinary
pathology and five years of practice, a board certified
pathologist with a year of formal training in genitourinary
pathology and two years of practice, and a pathology fel-
low in his fifth year of post-graduate training.
In addition to the study pathologists, a team of individu-
als with diverse and distinct backgrounds was required for
this study, including:
• A project manager and a principal faculty investigator (a
pathologist), responsible for the design, management,
integration, and overall execution of the study;
• Evaluators with the University of Pittsburgh Center for
Biomedical Informatics, responsible for protocol develop-
ment, IRB approvals, data management, and focus group
(de-briefing) interviews;
• The Quality Assurance Division of the Department of
Pathology, responsible for independent case selection;
• A laboratory information system (LIS) team, responsible
for "recreating" the study cases for sign-out by the study
pathologists through the LIS;
• The histology laboratory, responsible for recuts or spe-
cial stains requested by the pathologists during the study;
• An honest broker, responsible for de-identifying case
material; and
• An imaging team responsible for whole slide image cap-
ture, storage, and presentation.
Procedures and apparatus
The study was structured to enable study pathologists to
independently sign-out the same 25 archived cases as if
each case were "new" and each study pathologist was the
responsible case pathologist. The LIS and clinical standard
operating procedures for Shadyside Hospital were used
throughout the study. To this end, two important aspects
of the study workflow had to be implemented:Page 3 of 19
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receive and sign-out cases as well as to order special stains
and recuts.
2. Consistent with new cases, study pathologists initially
received only digitized images of the slides that the origi-
nal case pathologists initially received. Study pathologists
could request special stains and recuts as needed. When a
stain or recut was requested, if the stain had been ordered
and prepared for the original case pathologist, the existing
slide was imaged and presented to the study pathologist.
If the original case pathologist had not ordered the
requested stain or recut, the histology lab cut the block
and produced a new stained slide which was then imaged
and presented to the study pathologist.
The only differences between the study sign-out proce-
dure and the "original" or "real" sign-out procedure were
that study pathologists worked entirely through whole
slide images to diagnose the cases, they were not assisted
by residents, and they did not have access to the transcrip-
tion service.
Cases were limited to genitourinary pathology and der-
matopathology based on the interests of study patholo-
gists. Case selection was performed by the Department of
Pathology Quality Assurance Division and was not influ-
enced by study personnel. Cases were selected randomly
using an existing computer program in the LIS normally
used to select cases for quality assurance studies. The ini-
tial selection process resulted in five vasectomy cases,
three of which (case numbers 32, 34 and 41) were
removed before the study began and were replaced by
other randomly chosen cases. Once Quality Assurance
personnel assured that study pathologists were not previ-
ously associated with the selected cases, the case list was
presented to the LIS team.
The LIS team "recreated" each case so that it was presented
to the study pathologists in the same manner in which it
had been presented to the original case pathologist. This
involved removing microscope descriptions, final diag-
noses, diagnostic codes, records of special stains and
recuts, consultations, etc., and retaining case data in
demographic, clinical history and gross description fields.
Histology pulled all the sides for each case. The honest
broker "de-identified" the cases by eliminating all patient,
pathologist, accession and clinical identifiers (as well any
other HIPAA safe harbor data) from the reports. Study
numbers were assigned to each case and new (opaque)
slide labels with bar codes (for use in imaging), study
numbers, block and slide numbers and stain information,
were placed over the original labels. The project manager
and principal investigator (a pathologist) determined
which slides were "original" to the case and which repre-
sented special stains and recuts ordered by the clinical case
pathologist. Original slides were sent for imaging (vide
infra) while special stains and recuts were held by the
project manager and imaged only when and if requested
by a study pathologist (vide supra).
The study pathologists worked through the cases inde-
pendently, ordering special stains and recuts as needed.
Pathologists could not request that a slide be rescanned.
They did not have access to the original pathology report
or the glass slides and they did not discuss the cases
between them. LIS logs were examined to insure that
study pathologist did not attempt to use LIS text searches
to "find" original archived sign-out reports. Consultation
with other (non-study) pathologists was not discouraged,
but such "intra-departmental consultation" was, in fact,
very limited. For each case, each pathologist wrote a com-
plete diagnostic line, including a diagnostic comment if
appropriate.
After all cases were completed, study pathologists, evalua-
tors, the project manager and the principal investigator
met as a group to discuss results. The post-diagnostic dis-
cussion had two parts for each case:
1. Reports from the individual study pathologists were
compared. When there were discrepancies, the patholo-
gists discussed the case and examined the whole slide
images as a group to determine the nature and extent of
disagreement and the root of the discrepancy. Patholo-
gists then reached a "WSI consensus". The principal inves-
tigator wrote down this consensus diagnosis before
moving to the second part of the evaluation.
2. Once a consensus diagnostic line was agreed upon and
documented, the evaluation team, for the first time, pre-
sented the original, de-identified sign-out report to the
study pathologists and principal investigator. The team
then determined the extent of agreement between the WSI
consensus diagnosis and the microscopic-based diagnosis
of the original case pathologist. Discussions involved
detailed examination of the original pathology report, the
digital slides and the glass slides under a multi-headed
microscope.
The process was performed as if it were a strict quality
assurance protocol.
Case evaluation form and post study focus group
During the study, the pathologists were asked to fill out an
evaluation form for each case. The data collected included
subjective ratings of image quality (for each slide), case
complexity, diagnostic confidence and system perform-
ance.Page 4 of 19
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ducted a focus group interview with study pathologists.
Following a round-robin format, participants were asked
to contribute their thoughts on the key take-away lessons
from this project. Responses were audio-recorded and
transcribed. The evaluation team analyzed transcripts and
identified emerging themes.
WSI
Automated, whole slide image capture was performed on
an Aperio T2 slide scanner (Aperio Technologies, Vista
CA) outfitted with a Nikon Plan Fluor 20 ×, 0.7 Numerical
Aperture Objective Lens and Basler L301"trilinear array"
line scan camera. The system's spatial sampling period
(the area of tissue section subtended by a pixel) was
approximately 0.46 microns/pixel. The system ran in
automated batch mode with automated focus and tissue
finding. Images were compressed during the capture proc-
ess in a multi-layered JPG2000 format using a Matrox
Morphis compression board (Matrox Incorporated, Mon-
treal Canada) with a quality setting of 30 resulting in file
sizes ranging between 10 MB to 300 MB. The image server
was a Dell machine equipped with dual Xeon processors,
4 GB of RAM, and 1 TB of hard drive storage running
Microsoft Windows Server 2000, IIS and Aperio Image
Server software version 5.6.
Table 1: Case detail
Case Part Slides Specimen High Level Diagnosis
31 1 1 Bladder Biopsy Urothelial Carcinoma, High Grade
32
33 1 4 Donor Bladder Bx Chronic Cystitis, Moderate
34
35 1 2 Vasectomy Complete Excision, Bilateral
36 1 2 Vasectomy Complete Excision, Bilateral
37 1 3 Bladder Biopsy Urothelial Carcinoma, High Grade
38 1 3 Bladder Biopsy Chronic Cystitis & Granulomatous Inflammation
2 3 Bladder Biopsy Chronic Cystitis & Granulomatous Inflammation
39 1 3 Bladder Biopsy Urothelial Carcinoma, High Grade
40 1 3 Bladder Biopsy Urothelial Carcinoma, High Grade
41
42 1 9 Nephrectomy Renal Cell Carcinoma
43 1 2 Bladder Biopsy Chronic Cystitis & Granulomatous Inflammation
44 1 12 TURP Benign Prostatic Tissue
45 1 9 TURB Urothelial Carcinoma, High Grade
46 1 4 Skin Biopsy Dermal Nevus
47 1 2 Skin Biopsy Basal Cell Carcinoma
48 1 2 Skin Biopsy Mycosis Fungoides
49 1 2 Skin Biopsy Compound Nevus
50 1 3 Skin Biopsy Basal Cell Carcinoma
2 3 Skin Biopsy Compound Nevus
51 1 1 Skin Biopsy Neurofibroma
52 1 2 Skin Biopsy Inflamed Seborrheic Keratosis
53 1 1 Skin Biopsy Malignant Melanoma
54 1 4 Skin Biopsy Dysplastic Nevus
55 1 4 Skin Biopsy Compound Nevus
2 4 Skin Biopsy Nevus of Acral Skin
56 1 9 Prostate Biopsy Benign Prostatic Tissue
2 9 Prostate Biopsy Benign Prostatic Tissue
57 1 6 Prostate Biopsy Prostatic Adenocarcinoma, Gleason 7
2 6 Prostate Biopsy High Grade PIN
58 1 12 Prostate Biopsy Prostatic Adenocarcinoma, Gleason 6
2 12 Prostate Biopsy Prostatic Adenocarcinoma, Gleason 6
25 31 142
Description: Twenty-five genitourinary or dermatology cases (representing 31 individual parts) were selected randomly by the LIS. Cases 32, 34 and 
41 were vasectomy specimens that were removed before the study began and replaced by more challenging cases (chosen at random). The 142 
slides represented those originally cut on the case and did not include recuts and special stains ordered by the original sign-out pathologist. As part 
of their workup, the study pathologists ordered 68 recuts and special stains, making the total number of slides imaged in the study 210. "High Level 
Diagnosis" is the summary/abstraction from the first line from the original, sign–out diagnosis and can be used to judge the nature of the cases 
studied.
TURP = Transurethral resection of prostate
TURB = Transurethral resection of bladder tumorPage 5 of 19
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ning of the project. These images were grouped by case
and copied into three folders, one for each study patholo-
gist. During the study, 68 additional slides were imaged
representing recuts or special stains ordered by individual
study pathologists. These images were placed in the order-
ing pathologist's folder. Average slide capture speed was
approximately 6 minutes. Following automated image
capture, the imaging technician quickly examined each
image at low power for general image quality. On the
basis of this examination, 10 of 210 slides showed evi-
dence that "tissue finding" function had failed and that
significant areas of the tissue had not been imaged (this
usually involved immunohistochemistry slides with light
counter staining). In those cases, the technician manually
adjusted the imaging window and let the system re-
imaged the slide. There were no other technical problems
with image capture.
Pathologists viewed the whole slide images through net-
work connections on remote workstations located in their
hospital offices or at their homes. Intra-hospital connec-
tions used a 100 Mbps switched Ethernet line, while off-
site connections were physically limited to ISP connection
speeds (approximately 1.5 Mbps). In virtually all cases,
workstations and the server were on different sub-net-
works. Workstations (and monitors) used to view the
whole slide images varied greatly, ranging from laptops to
typical current-generation hospital workstations. Viewer




The study was performed during a four-week period on 25
pathology cases with 31 individual parts representing 26
diagnostic biopsies, two vasectomies, a nephrectomy, a
transurethral resection of the prostate, and a transurethral
resection of the bladder (Table 1).
As discussed in the Methods section, the study can be con-
sidered in two related parts. In the first, the three study
pathologists used WSI to independently diagnose each
case with a complete written diagnostic line and comment
(if necessary), and the consensus committee compared
those reports, documented discrepancies between them
and formed a consensus WSI diagnosis that was then writ-
ten down by the principal investigator. In the second part,
the consensus WSI diagnosis was compared to the tradi-
tional microscope-based report of the original sign-out
pathologist and any discrepancies were examined. Results
for each part of the study are presented separately.
The Appendix, an additional file submitted with this
paper, includes the WSI-based diagnoses of the individual
study pathologists, the WSI consensus diagnoses, and the
original, traditional microscope-based, sign-out diag-
noses for each case. It also documents the judgments of
the consensus committee in forming the WSI consensus
diagnoses and the comparison of the WSI consensus diag-
noses with the original sign-out reports. The results pre-
sented below can be examined further by referring to the
Appendix.
WSI concordance between study pathologists
In the first phase of the study, three pathologists signed
out 25 cases representing 31 specimens (parts). This
resulted in 93 independent "diagnoses" each of which
included multiple (variable) diagnostic lines (e.g.,
Urothelial Carcinoma: Grade 2 of 3: tumor is confined to
the lamina propria: Angio-lymphatic invasion is not iden-
tified). In 16 of 25 cases, representing 21 of 31 parts, there
was complete agreement across the WSI-based diagnoses
of the three study pathologists. In the remaining 10 parts,
there were 12 diagnostic discrepancies with 2 parts having
2 discrepancies. Image quality is potentially implicated in
3 of these 12 discrepancies as discussed below.
The 12 diagnostic discrepancies between the individual
WSI-based reports can be classified into four main types
using data from the consensus committee (Appendix).
Table 2 summarizes this information.
Type 1 discrepancies: These represent situations in which
a pathologist misdiagnosed a fairly straightforward, well-
imaged lesion.
There were two such cases:
▪ Case 54 was an excision of a dysplastic nevus and neu-
rotized dermal nevus. A pathologist reported (in addition
to the diagnosis above) an actinic keratosis at the edge of
the resection (Figures 1, 2, 3 and 4). At the WSI consensus
committee meeting, the other pathologists convinced him
that, because there was no atypia and no significant solar
elastosis, the area was most likely tangential cut through a
fold at the edge of the section.
▪ Case 52 was a shave biopsy of skin. A pathologist diag-
nosed actinic keratosis citing mild atypia in the epithe-
lium (Figures 5 and 6). In committee however, the
pathologists agreed that the findings best fit the diagnosis
of inflamed seborrheic keratosis with human papilloma
virus (HPV) involvement as the atypia was limited to the
superficial (not basal) layers, there was a "warty" koilocy-
totic appearance to the atypical cells and there was a lack
of appreciable solar elastosis.
The root cause of these type 1 discrepancies seemed to be
lack of experience signing out dermatopathology casesPage 6 of 19
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not play a role in the errors.
Type 2 discrepancies: In these situations, a pathologist did
not look at (and therefore did not report on) an area con-
taining a clear, well-imaged lesion.
There were three such discrepancies, two in the same case:
▪ Case 38 was a two part bladder biopsy that showed
chronic inflammation and no neoplasia. There were three
levels cut on each part. In part 1, two of the three pathol-
ogists missed a focal area suspicious for non-necrotic
granulomatous inflammation clearly visible on the WSI
image. In part 2, in the last level, there was definite gran-
uloma by WSI (Figure 7). Two of the three pathologists
did not see (or report on) these lesions as they were con-
scientiously seeking neoplasia in the epithelium.
▪ In Case 55, a skin biopsy, one of the pathologists diag-
nosed a junctional nevus and overlooked a small dermal
component.
The root cause of these discrepancies seemed to be that
the pathologist did not look at and therefore did not "see"
the lesion. There was little evidence that image quality was
at fault as once the lesion was pointed out there was no
question or debate of its presence or significance. How-
ever, it is possible that the relative novelty of examining
cases on the monitor (and navigating with a mouse) may
have contributed to these errors.
Case 54, neurotized dermal nevusFigure 2
Case 54, neurotized dermal nevus. Case 54 included a 
dysplastic nevus and neurotized dermal nevus. Figure 2 docu-
ments the dermal nevus at medium resolution.
Table 2: Discrepancies between individual study pathologists' WSI-based reports
Case Part Specimen At Issue Discrepancy Type
37 1 Bladder Biopsy Tumor Grade* Type 3
38 1 Bladder Biopsy Dysplasia v Benign Type 4*
Granulomatous Inflammation? Type 2
2 Bladder Biopsy Granulomatous Inflammation? Type 2
40 1 Bladder Biopsy Tumor Grade Type 3
Superficial Invasion? Type 3
45 1 Bladder Biopsy Muscle Invasion? Type 1
50 2 Skin Biopsy Atypical Melanocytic Lesion: Invasion? Type 4*
52 1 Skin Biopsy Actinic Keratosis versus Seborrheic Type 3
Keratosis with HPV infection
54 1 Bladder Biopsy AK versus Artifact Type 3
55 1 Skin Biopsy Junctional versus Compound Nevus Type 2
57 2 Prostate Bx Atypical Glands (Cancer v HGPIN) Type 4*
Description: There were 12 discrepancies between study pathologists' WSI-based reports. Of these, sub-optimal image quality was implicated in 4 
instances (38, 50 and 57). See text for the definition of the "discrepancy types".
Case 54, dysplastic nevusFigure 1
Case 54, dysplastic nevus. Case 54 included a dysplastic 
nevus and neurotized dermal nevus. Figure 1 documents the 
dysplastic component at medium resolution.Page 7 of 19
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agreed on what they saw but disagreed on how to report
it. These cases involved significant, legitimate diagnostic
uncertainties and tended to reflect differences in judg-
ments on grading in borderline cases or aggressiveness in
interpreting superficial invasion in the context of intense
inflammation. To qualify as a type 3 discrepancy, there
needed to be convincing evidence that image quality did
not contribute to the differences in judgment.
There were three such discrepancies:
▪ In Case 40, a bladder biopsy positive for urothelial neo-
plasia, one discrepancy involved potential superficial
invasion of the lamia propria in the context of extensive
inflammation (Figures 8 and 9). The study pathologists
reported different opinions. One called it in situ disease,
one called it superficial invasion, and one hedged –
reporting that "definitive invasion could not be identi-
fied" (Appendix). During consensus committee discus-
sion and examination of the images, it was agreed that,
although there was legitimate suspicion of invasion, no
definitive foci of invasion could be identified. Signifi-
cantly, the original sign-out pathologist (using the micro-
scope) had reached the same conclusion on H&E slides,
and the study pathologists were not swayed from their
WSI-based opinions when they later examining the case
under a microscope. This case is discussed further below.
▪ A second discrepancy in Case 40, involved low versus
high-grade neoplasia. This was a difficult call even under
the microscope (Appendix). In many areas, the lesion
appeared low grade – it did not show marked nuclear pol-
ymorphism or increased nuclear size (Figure 9). However
there were foci in which the cells were crowded and had a
high nuclear/cytoplasmic ratio (Figure 10). After discus-
sion, it was decided that the tumor should be considered
a high-grade neoplasm.
▪ Case 45, a transurethral resection of a bladder tumor,
had a similar scenario. In this case the uncertainty
involved potential invasion of the detrusor (Appendix).
▪ Case 37, a bladder biopsy, the question involved low-
grade versus high-grade urothelial cancer and image qual-
ity seemed to be good. Two study pathologists called for
high-grade and one for low-grade. It was a judgment case
and consensus opinion was for high-grade. (Figures 11,
12 and 13).
In Case 40 and 45 discrepancies appeared to arise from
personal reporting styles and aggressiveness when faced
with a legitimately difficult case. WSI quality did not
appear to factor into the discrepancies. The root cause of
type 3 discrepancies was that these were difficult cases
with legitimate uncertainty requiring pathologist judg-
ment. Significantly, the consensus WSI diagnosis turned
Case 54, Tangential cut called an actinic keratosisFigure 4
Case 54, Tangential cut called an actinic keratosis. 
Case 54 included a dysplastic nevus and neurotized dermal 
nevus. One pathologist also reported an AK at the edge of 
one of the sections. Consensus was that "AK" was actually a 
tangential cut at edge of section.
Case 54, Tangential cut called an actinic keratosisFigure 3
Case 54, Tangential cut called an actinic keratosis. 
Case 54 included a dysplastic nevus and neurotized dermal 
nevus. One pathologist also reported an AK at the edge of 
one of the sections. Consensus was that the "AK" was actu-
ally a tangential cut at edge of section. See Figure 4 for higher 
power view.Page 8 of 19
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report in all cases (vide infra).
Type 4 discrepancies: In these cases, image quality was
implicated (at least partially) in the disagreements
between pathologists.
There were three such instances:
▪ In Case 38, a bladder biopsy, one pathologist reported a
focus of high-grade dysplasia while the others reported
benign epithelium. Consensus was that the area in ques-
tion was "suspicious but not convincing of dysplasia" by
WSI. The area had epithelial cells with large, dark nuclei
and no umbrella cells present; however, similar morphol-
ogy was seen in other areas covered by umbrella cells (Fig-
ure 14). Much of the epithelium seemed slightly out of
focus. Traditional microscopic examination (done later)
seemed to expose more nuclear detail and made it easier
to determine that the epithelium was not dysplastic.
▪ In Case 50, a two part skin biopsy, the first part was a
basal cell carcinoma and caused no disagreement. In the
second part, however, one pathologist (a board certified
dermatopathologist) reported a dysplastic nevus (Figure
15) while the other two pathologists reported "atypical
melanocytic lesion" and wrote long comments (Appen-
dix). While favoring dysplastic nevus, one was concerned
by "areas where single melanocytes are increased in
number" (Figure 16) while the other was worried about
"atypical melanocytes in the dermis". In consensus, it was
agreed that dysplastic nevus was the appropriate diagno-
sis. This was a legitimately difficult case, but because small
areas of the epithelium were out of focus (for example, the
upper right in Figure 16) and because dermal melanocytes
were difficult to interpret (Figure 17), it was considered a
type 4 discrepancy.
▪ Case 57 was a prostate biopsy. Part 1 had carcinoma and
engendered no disagreement. Part 2, however, contained
a focus of atypical glands. One pathologist called it "sus-
picious for carcinoma" and one called it carcinoma out-
right. Special stains were non-contributory. After
significant discussion, it was agreed that carcinoma could
not be definitively diagnosed in the image. The field (Fig-
ures 18 and 19) was slightly out of focus so image quality
was a confounding factor. However, examination under
the microscope (in the second part of the study) did not
appear to make the decision any easier.
Image quality is implicated (at least partially) in three type
4 discrepancies (Case 38, 50 and 57). However, it is
important to note that in all these cases, WSI-based con-
sensus turned out to be in agreement with the (micro-
scope-based) original sign-out report (vide infra).
Therefore, even though image quality may be implicated
in these discrepancies between pathologists and may have
caused confusion, there was enough image information
available for a correct diagnosis (vide infra, Discussion).
Concordance between the WSI consensus diagnosis and 
the original, microscope-based sign-out report
After examining the individual WSI-based reports during
the consensus committee meeting the pathologists agreed
Case 52, seborrheic keratosisFigure 6
Case 52, seborrheic keratosis. Case 52 was a seborrheic 
keratosis. One study pathologist diagnosed actinic keratosis 
citing the mild atypia in the epithelium. Consensus was that 
the correct diagnosis was seborrheic keratosis. The atypia 
may have been secondary to human papilloma virus (HPV). 
Figure 5 shows a lower power view of a tissue section.
Case 52, seborrheic keratosisFigure 5
Case 52, seborrheic keratosis. Case 52 was a seborrheic 
keratosis. One study pathologist diagnosed actinic keratosis 
citing the mild atypia in the epithelium. Consensus was that 
the correct diagnosis was seborrheic keratosis. Figure 6 
shows a higher power including some of the atypical cells in 
the epithelium.Page 9 of 19
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sensus diagnosis was written down and then the patholo-
gists were presented, for the first time, with the original,
microscope-based, signed-out diagnosis for each case.
These data are available in the Appendix.
All 25 cases and 31 parts showed agreement between the
WSI consensus diagnosis and the original, microscope-
based, sign-out report. Had this been a surgical pathology
quality assurance exercise, the study pathologists would
not have called a single, even mild, disagreement. This
was a remarkable and unexpected finding.
In 21 of the 25 cases, there was line-by-line concordance
and these cases were considered in "complete" agreement
with the original sign-out report. Four cases had minor
differences that required discussion prior to a determina-
tion of agreement. These are discussed below.
In part one of Case 38, a bladder biopsy that showed
chronic inflammation and reactive changes, the sign-out
report called "focal submucosal non-necrotizing granulo-
matous inflammation". This was in mild disagreement
with the WSI consensus diagnosis, which reported "focal
area suggestive of granulomatous inflammation" (Figure
20). After examining the case under the microscope, how-
ever, the study pathologists continued to maintain that
the findings supporting non-necrotizing granulomatous
inflammation were not completely conclusive and that a
diagnosis of "focal area suggestive of granulomatous
inflammation" was the most appropriate diagnostic line.
The issue appeared to be a matter of pathology judgment
and reporting style. If this had been a quality assurance
review, in the opinion of the study pathologists, it would
not have generated a disagreement, especially since non-
necrotizing granulomatous inflammation was definitively
called on both imaging and glass slide in the second part
of the case (Figure 7). Further, it was clearly not an issue
of image quality, as the images were clear and microscopic
examination did not cause the study pathologists to
change their view. The principle investigator, with the
consent of the study pathologists, therefore classified this
case as in "basic" agreement.
In Case 40 (Figure 8 and 9), a bladder biopsy with high-
grade papillary urothelial carcinoma, the issue involved
"potential superficial invasion of the lamina propria". It
was a very difficult case with marked reactive change. The
long diagnostic comment in the original sign-out report
confirms the complexity of the case (Appendix) and all of
the study pathologists indicted that they would have done
an internal consultation before signing it out. Neither the
WSI consensus nor the microscope-based original pathol-
ogist could document definitive invasion of the lamina
propria on H&E stains. The original pathologist, however,
ordered and examined an immunohistochemical stain for
wide spectrum cytokeratin that confirmed the suspicion
of focal, superficial invasion.
The classification of this case was difficult. None of the
study pathologists ordered cytokeratin on this case,
though all had the opportunity to do so. On the other
hand, the WSI consensus diagnosis did not call the case
Case 40, bladder biopsy with inflammationFigure 8
Case 40, bladder biopsy with inflammation. Intense 
inflammation made evaluation of superficial invasion difficult, 
even under the microscope. Figures 9 and 10 show higher 
power views.
Case 38, granulomatous inflammationFigure 7
Case 38, granulomatous inflammation. A clear granu-
loma missed by two pathologists as they steadfastly searched 
for neoplasia in the epitheliumPage 10 of 19
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definitive invasion of the lamina propria is identified"
and added a comment that "marked reactive changes
make it difficult to evaluate this neoplasm". If this had
been a quality assurance review, the study pathologists
would have had access to the special stains slides used by
the original pathologist and would have likely agreed
completely with the sign-out report. Because there was no
definitive evidence of invasion by H&E and because the
WSI consensus diagnosis hedged the issue of superficial
invasion the case was classified as "basic" agreement.
In Case 42, a nephrectomy for renal cell carcinoma, there
were two issues (Appendix 1):
1. The consensus WSI diagnosis reported a Fuhrman's
Nuclear Grade of III/IV (Figure 21), disagreeing with the
sign-out diagnosis of Fuhrman's Grade of II/IV. Interest-
ingly, the individual WSI reports were split on Fuhrman's
Grade, two reporting III and one reporting II.
2. The WSI consensus diagnosis of "unremarkable non-
neoplastic kidney" conflicted with the original sign-out
pathologist report of "non-neoplastic kidney with chronic
pylonephritis". Again, in the individual WSI reports, two
pathologists called the non-neoplastic kidney "unremark-
able" while the third called "mild interstitial nephritis".
It was agreed that these discrepancies would not have
caused a disagreement if this had been a QA review. Fur-
thermore, after examining the case under the microscope,
the pathologists stood by their WSI consensus diagnoses
of Fuhrman's Grade III/IV and unremarkable, uninvolved
kidney. The case was therefore classified "basic" agree-
ment. There were no image quality issues evident (Figure
21).
In Case 45, a trans-urethral resection of a high-grade
urothelial carcinoma, the question involved potential
invasion of the detrusor muscle (Appendix). The original
sign-out pathologist (using the microscope) had reported
that "adequate detrusor muscle is identified without inva-
sion", however, the WSI consensus diagnosis reported
"tumor invades the lamina propria" and included the fol-
lowing diagnostic comment: "carcinoma invades at least
to the lamina propria, however, due to extensive thermal
artifact and tangential sectioning, invasion of the detrusor
muscle cannot be completely ruled out." The study
pathologists examined the slides under the microscope,
and could not be swayed from their opinion. Because
both reports concluded the tumor was in the lamia pro-
pria and not definitively in the detrusor, the case was clas-
sified as one of "basic" agreement. There was no issue of
image quality.
Case evaluation form
In addition to writing a diagnostic report, the study
pathologists were asked to complete an evaluation form
on each case. Data were collected on image quality, case
complexity, diagnostic confidence and system perform-
ance.
Figure 22 summarizes the pathologists' opinion of image
quality. Virtually all of the whole slide images were felt to
be either "excellent" ("Flawless – superb color and sharp-
ness/focus") or "diagnostic" ("Minimal distortion – qual-
ity is high enough to render a diagnosis"). Only seven
images were rated "poor" ("Extreme distortion – quality
Case 40, bladder biopsy with inflammationFigure 10
Case 40, bladder biopsy with inflammation. In several 
foci, the tumor cells seemed to loose polarity and had a high 
nuclear/cytoplasmic ration. Figure 8 shows a lower power 
view.
Case 40, bladder biopsy with inflammationFigure 9
Case 40, bladder biopsy with inflammation. Intense 
inflammation made evaluation of superficial invasion difficult, 
even under the microscope. Much of the tumor appeared 
low grade. Figure 8 shows a lower power view.Page 11 of 19
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no single whole slide image was rated "poor" by more
than one pathologist. Six of seven times, the reason for a
"poor" rating was that "key areas were out of focus".
Figure 23 indicates the pathologists' opinion of the "com-
plexity" of the cases used in the study. "Complexity" is a
qualitative measure that involves the diagnostic difficulty,
the difficulty of case management (i.e. the need for recuts
or special stains) and the difficulty required in expressing
a complete and meaningful diagnostic report. The results
indicated that the study included a balanced set of cases
with "high", "medium" and "low" complexity.
Figure 24 shows the degree of confidence pathologists had
in their WSI-based diagnoses. Despite the relative novelty
of WSI, diagnostic confidence was high. Out of 72
responses, there were three instances of "low" diagnostic
confidence (involving cases 30, 35 and 51). These cases
did not involve instances of "poor" image quality and did
not turn out to result in diagnostic discrepancies between
pathologists.
Figure 25 gives an impression of the pathologists' satisfac-
tion with the performance of the display system. While
the data is by no means quantitatively significant, system
performance (stability, response times and ease of use)
was felt to be excellent to good in most cases.
Figure 26 displays the "time to complete" each case.
Though useful, this data is very hard to interpret as it
includes not only "monitor time" but also time required
to write the report, order stains and, in some cases, work
directly with the histology lab to identify and orient
blocks.
In general, data from the evaluation forms indicated that
the study included a reasonable spectrum of complexity,
image quality was considered good, and diagnostic confi-
dence was high. It also indicated that, though system per-
formance (stability, response times and ease of use) was
generally good, sign-out times seemed to be longer with
current WSI technology than with traditional microscopic
examination.
Focus group de-briefing
The post study focus group exercise was designed to allow
study pathologists to voice opinions on issues that may
not be directly related to the study's goals. Four main
themes were identified: 1) image quality, 2) monitor
quality, 3) viewer functionality, and 4) the effect of expe-
rience.
Image quality was felt to be good but not perfect. While
the great majority of images were considered diagnostic
(vide supra), virtually all slides had some areas that were
slightly out of focus. These were often described as areas
of "softness". One pathologist stated, "...the images were
better than those from a resident's microscope but not as
good as those through an attending's microscope". These
comments seemed consistent with the results from the
evaluation form and success of the main primary diagno-
sis section of the study.
All three pathologists felt that the monitor was a major
factor in perceived image quality. Though pathologists
disagreed on which type of monitor was better (LED ver-
sus CRT), there was strong agreement that, within a given
type, higher, more expensive monitors provided much
better image quality (and diagnostic confidence). Interest-
ingly, all pathologists agreed that at a given monitor reso-
lution, larger monitors provided better images that were
Case 37, bladder biopsy with urothelial carcinomaFigure 12
Case 37, bladder biopsy with urothelial carcinoma. 
Medium view of a tissue fragment, the diagnostic question 
was high grade versus low grade. Figures 11 and 13 show 
additional views
Case 37, bladder biopsy with urothelial carcinomaFigure 11
Case 37, bladder biopsy with urothelial carcinoma. 
An overview of the specimen, the diagnostic question was 
high grade versus low grade. Figures 12 and 13 show higher 
powersPage 12 of 19
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to a 20 inch monitor... A larger monitor made things a lot
more comfortable and intuitive for me". Another said, "
[The quality of] whole slide images varies with the quality
of monitor used as [the quality of] glass slide images var-
ies with the quality of microscope used". These findings
are important as the manufactures of WSI equipment are
largely focused on improving the quality of image cap-
ture, not image display.
Viewer functionality was an area of extensive discussion.
The viewer used in the study was similar to others used in
the industry. It used a single monitor, numerous mouse-
activated buttons and controls, and a small "navigator" or
"thumbnail" window to orient the user to the slide. Clin-
ical information and image metadata were displayed in a
separate window, competing with the main image for
"monitor real estate". The viewer also had no capability to
view "thumbnails" of all slides from a given case at the
same time (a "slide tray" functionality). The study pathol-
ogists found several problems with the design. While
there was much debate over details, several important
themes emerged:
• The pathologists were irritated that they needed to take
their eyes off of the image to move a curser to a button
each time they wanted to change magnification, etc. They
all expressed the need for more intuitive, less invasive con-
trols.
• The pathologists felt that panning or scanning at low or
medium magnification was clumsy and slow. This was
not an issue of network/server response time as response
times were quite fast. Essentially, the "thumbnail" was too
small and did not have enough resolution for diagnostic
use and the field of view in the main image window was
too small (vide infra). This forced the pathologists to scan
through many, relatively low or mid-power fields to eval-
uate a specimen such as a TURP and may have contributed
to the "type 2" errors seen in cases 38 and 55.
• The lack of a thumbnail "slide box" made it difficult to
evaluate a case prior to detailed examination of each slide.
Discussion of viewer functionality and monitors led to a
discussion of the ideal viewing work-station. According to
the study pathologists, the ideal system would have three
monitors: a small monitor to display clinical data and
image metadata; a large, high-resolution monitor with the
same aspect ratio as the slide, mounted horizontally for
navigation and to provide an uninterrupted, low to mid-
dle resolution image of the entire slide; and a high quality,
17–21 inch monitor for high-resolution evaluation of
specific areas. The mouse and keyboard were felt to be less
than optimal for controlling the system.
Finally, it was agreed that pathologists seemed to get bet-
ter at WSI interpretation with experience. Comments
included: "...it gets better as you look at a lot of WSI. You
learn to maneuver, adapt and acquire short cuts." "WSI
Case 38, bladder biopsy with urothelial carcinomaFigure 14
Case 38, bladder biopsy with urothelial carcinoma. 
High power view of the epithelium. The field is slightly out of 
focus, the epithelial cells are dark and one cannot appreciate 
and detail in their nuclei. Umbrella cells are clearly visible the 
upper part of image, but are not present in the center and 
lower areas. Without umbrella cells, it might be difficult to 
distinguish between a benign or dysplastic epithelium. There 
are at least to image problems present: focus and dynamic 
range (lack of detail in the dark nuclei). Though nuclei can be 
dark for reasons not related to images (i.e. histologic stain-
ing), in this case better nuclear detail was appreciated under 
the microscope.
Case 37, bladder biopsy with urothelial carcinomaFigure 13
Case 37, bladder biopsy with urothelial carcinoma. 
High power view of a tissue fragment, the diagnostic question 
was high grade versus low grade. Figures 11 and 12 show 
additional viewsPage 13 of 19
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details of the process." And, "As I see more [images] I get
pickier; I can pick up small focusing flaws and compres-
sion artifacts." There seems to be a learning curve. It is not
steep, but it did exist.
Discussion
The main goal of this study was to evaluate the clinical
utility of current automated, high-speed, high-resolution,
WSI robots by evaluating the ability of pathologists to
sign-out complex cases exclusively through digital slides
created by those devices. The study had two related com-
ponents. In the first, three study pathologists independ-
ently "signed-out" 25 genitourinary pathology and
dermatopathology cases exclusively with digital slides.
Each pathologist composed a complete final diagnosis
including diagnostic comments when appropriate. The
work was done through our institution's LIS workflow
and the pathologists could order special stains and recuts.
The reports from the different pathologists were then
compared, discrepancies examined, and a consensus diag-
nosis was rendered. In the second part of the study, the
WSI consensus diagnosis was compared with the micro-
scope-based, sign-out report of the original case patholo-
gist.
The comparison of the WSI consensus diagnosis with the
original microscope-based, sign-out report had a remark-
able and unexpected result. There was virtually complete
diagnostic agreement between the WSI-based report and
the microscope-based report for all 31 surgical parts of the
25 cases examined. The results seem to indicate that the
image information contained in current whole slide
images is sufficient for pathologists to make reliable diag-
nostic decisions and complex diagnostic reports. This
should be very encouraging to the WSI industry; however,
these results should not be interpreted as implying that
automated, high-speed whole slide images are "as good
as" the microscope. In fact, every whole slide image in the
study had a least some areas of imperfect focus, and some
had what appeared to be compression artifact. In other
words, what seems to be impressive diagnostic capability
reported in this study should not be construed to mean
the images obtained in the study were perfect, or that they
were as good as the images formed on the retinal by a
well-aligned microscope.
The comparison between the individual WSI-based
reports of the study pathologists was also encouraging. In
17 of the 25 cases (21 of 31 specimens/parts) the reports
of the study pathologists showed complete agreement. Of
the 12 documented discrepancies (in 10 specimens/
parts), 9 did not appear to involve image quality issues
but three did (vide supra, Results). Looking at this in
another way, there were three pathologists who independ-
ently rendered extensive diagnoses on 31 parts (93 diag-
nostic events). Of these 93 events, image quality and/or
interpretation issues were implicated, at least partially, in
3 (in cases 38, 50 & 57). It is these cases that are the most
interesting and informative. The majority of these discrep-
ancies involved largely cytologic decisions along the con-
tinuum of benign, atypical, suspicious to malignant, and
while the WSI consensus arrived at the correct diagnosis,
the pathologists agreed that examination under the micro-
scope made the decision much easier.
Case 50, dysplastic nevusFigure 16
Case 50, dysplastic nevus. Less than perfect imaging con-
tributed to confusion in the case. In this field, numerous epi-
thelial melanocytes caused concern for one pathologists that 
that was magnified because foci were slightly out of focus (i.e. 
upper left corner).
Case 50, dysplastic nevusFigure 15
Case 50, dysplastic nevus. Less than perfect imaging con-
tributed to confusion in this case. While all pathologists felt 
that the lesion was a dysplastic nevus, two pathologists could 
not completely rule out melanoma on H&E stains.Page 14 of 19
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some degree of poor focus in the areas in question result-
ing in blurring of nuclear details. In some cases this may
be exacerbated by compression artifact and some degree
of limited dynamic range (causing dark area, like nuclei,
to appear darker than under the microscope). It is very
likely that these effects interact with each other (i.e. poor
focus blurs features that may be further eroded by com-
pression). While compression artifact can be improved by
changing compression parameters, methods for focus and
dynamic range appear to require further development for
automated, high-speed WSI systems to be used confi-
dently in clinical primary diagnosis. We are examining
these features carefully with controlled experiments and
will report our findings in a separate publication.
It is important to note that these effects, though they were
identified as causes of discrepancies in a relatively small
number of cases and did not cause a single mis-diagnosis
in consensus, could, in fact, be seen in the great majority
of slide images in this study. Virtually every whole slide
image had some areas of limited focus and some had
areas of what appeared to be compression artifact. How-
ever, pathologists could "read around" these areas to find
areas of excellent image quality, and they quickly learned
how to interpret these "artifacts". For example, Figure 27
shows an area in a prostate biopsy with poor focus and
other artifacts (it is from a whole slide image that had
excellent focus over large areas). Given the ability to eval-
uate the entire slide, the pathologists had no problem
identifying this area, correctly, as cancer.
The study was designed to measure a very specific thing:
the ability of pathology to sign-out completed cases using
currently available commercial WSI technology. This
study was conducted using an Aperio "T2" high-speed,
high-resolution, automated WSI robot. We have several
different WSI devices in our lab, from a number of ven-
dors. We chose the Aperio for this study because Aperio is
the market leader today, making it a good example of a
"typical" modern, WSI device. It is our experience that the
results of this study, the good and the bad, are to some
degree representative of all automated, high-speed devices
we have seen, and they spring from the same limitations
that all high-speed devices share – the challenges of focus,
speed, and compression.
The study involved a small number of pathologists and a
relatively small number of cases. Its interpretation
required the comparison of complex, free text diagnostic
reports. These limitations make it difficult to generate
meaningful statistics and should be taken into account
when evaluating the conclusions presented. It should also
be noted that the design of a study can significantly
impact its results. In the current evaluation, we did a line-
by-line comparison of the written reports of study pathol-
ogists using WSI, then had the same pathologists develop
a written consensus WSI report. We then compared that
report, line by line, with the original microscope-based,
sign-out clinical report. We felt that this approach allowed
us to examine the variation between study pathologists,
and, at the same time, to compare a consensus opinion
against a clinical "gold standard". Other approaches were
Case 57, prostate biopsyFigure 18
Case 57, prostate biopsy. The study pathologists disa-
greed about this focus. Opinions ranged from benign to sus-
picious to outright cancer. Special stains were non-
contributory. After discussion, it was agreed that cancer 
could not be definitively diagnosed. This turned out to be 
consistent with the signed report. The area is slightly out of 
focus. Figure 19 shows a higher power view.
Case 50, dysplastic nevusFigure 17
Case 50, dysplastic nevus. Less than perfect imaging con-
tributed to confusion in the case. This field shows dermal 
melanocytes that were difficult to interpret. The pathologist 
requested immunoperoxidase stains to evaluate the lesion 
further.Page 15 of 19
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pathologists to a modality (WSI or microscope), com-
pared reports, and changed assignments for every case.
Given the range of experience in our pathologists (and the
limited number of case), this could have caused signifi-
cant bias and would not have given us a gold standard
report to judge against. Alternatively, we could have had
the same pathologists see the same cases with both
modalities, separated by a time period long enough for
the pathologists to forget their initial impression. How-
ever, given the complexity of some of the cases and the
need for diagnostic comments, recuts and special studies
on a significant number of the cases, we felt that the
required latency time period would be prohibitively long,
especially given that rapid technical progress of whole
slide imaging systems. It is also important to note that, in
comparison studies, the way that "agreement" and "disa-
greement" are judged (for example, line by line compari-
son of written reports or a simple "benign versus
malignant"), clearly affects the reported results. Because of
this real effect, we decided to make all of our data availa-
ble in a supplemental file (Appendix 1) so that readers can
better interpret the findings for themselves. In the future,
to better assess the capabilities of current WSI technology
and to validate our findings we plan to build on this
study, including more controlled assessments of condi-
tions that may impact the performance, user attributes
and application of WSI across a variety of clinical environ-
ments.
Conclusion
Automated, high-speed, high-resolution WSI is an evolv-
ing technology that holds great promise for pathology
practice. At least in this study, the results indicated that
images produced by current devices have enough image
information to allow pathologists to produce accurate,
complex, and detailed diagnostic reports, even for diffi-
cult and complex cases. It is important, however, to recog-
nize that current images have significant limitations that
Case 52, nephrectomy for renal cell carcinomaFigure 21
Case 52, nephrectomy for renal cell carcinoma. The 
study pathologists (reading from both whole slide images and 
directly through a microscope) gave this tumor a Fuhrman's 
Nuclear Grade of III/IV. The grade in the signed out report is 
ll/lV.
Case 57, prostate biopsyFigure 19
Case 57, prostate biopsy. The study pathologists disa-
greed about this focus. Opinions ranged from benign to sus-
picious to outright cancer. Special stains were non-
contributory. After discussion, it was agreed that cancer 
could not be definitively diagnosed. This turned out to be 
consistent with the signed report. The area is slightly out of 
focus. Figure 18 shows a lower power view.
Case 38 Part 1, The signed out report diagnosed "focal sub-mucosal non-necrotiz ng granulomatous inflammati n"Figure 20
Case 38 Part 1, The signed out report diagnosed "focal sub-
mucosal non-necrotizing granulomatous inflammation". The 
study pathologists (reading from both whole slide images and 
directly through a microscope) were more comfortable in 
reporting "focal area suggestive of granulomatous inflamma-
tion".Page 16 of 19
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optimal focus and artifacts that appear to be related to
over-compression and limited dynamic range. These lim-
itations must be kept in mind if WSI is to be used for rou-
tine clinical primary diagnosis or other clinical
applications such as quality assurance or second opinion
collaboration. We are beginning to understand these tech-
nologies more clearly and this should allow pathologists
to better use, and manufactures to better build, WSI sys-
tems in the future.
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Perceived case complexityFigure 23
Perceived case complexity. Each pathologist rated each 
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nostic difficulty, case management (i.e. the need for recuts or 
special stains), and reporting issues (i.e. the need for a diag-
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Case 57, poorly imaged area of adenocarcinomaFigure 27
Case 57, poorly imaged area of adenocarcinoma. This 
image shows several image problems. The field was poorly 
focused and the nuclei appear smeared. Because the rest of 
the case had reasonably good imaging (including other levels 
of the same lesion), the pathologists could easily read around 
the artifact and arrived at the correct diagnosis.
System performanceFigure 25
System performance. Ratings provided an impression of 
pathologists' satisfaction with system performance (stability, 
response times and ease of use). The data is not quantita-
tively significant, but system performance was felt to be 
excellent to good in most cases.
Time to case completionF gure 26
Time to case completion. Though useful, this data was 
very hard to interpret as it included not only "monitor time" 
but also time required to write the report, order stains and, 
in some cases, work directly with histology lab to identify and 
orient blocks.Page 18 of 19
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